JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4726
HBT Financial
HBT
$1.32B
| $295K | ﹤0.01% |
14,458
-13,540
| -48% | -$258K |
2019 Q4
18 quarters
|
|
4727
WisdomTree Mortgage Plus Bond Fund
MTGP
$71.3M
| $294K | ﹤0.01% |
6,808
-12,079
| -64% | -$518K |
2023 Q2
4 quarters
|
|
4728
Franklin International Core Dividend Tilt Index ETF
DIVI
$2.65B
| $294K | ﹤0.01% |
9,390
+930
| +11% | +$29.7K |
2023 Q2
4 quarters
|
|
4729
Montauk Renewables
MNTK
$409M
| $293K | ﹤0.01% |
51,411
-208,671
| -80% | -$965K |
2021 Q1
13 quarters
|
|
4730
FT Vest US Equity Buffer ETF October
FOCT
$1.21B
| $293K | ﹤0.01% |
7,047
-14,172
| -67% | -$579K |
2022 Q4
6 quarters
|
|
4731
Burke & Herbert Financial Services Corp
BHRB
$1.41B
| $291K | ﹤0.01% |
5,709
-1,588
| -22% | -$80.9K |
2023 Q2
4 quarters
|
|
4732
AnaptysBio
ANAB
$1.45B
| $290K | ﹤0.01% |
11,580
-1,794
| -13% | -$41.8K |
2017 Q1
29 quarters
|
|
4733
CALL
Groupon
GRPN
$785M
| $289K | ﹤0.01% |
18,900
-4,500
| -19% | -$60.1K |
2023 Q2
4 quarters
|
|
4734
Granite Ridge Resources
GRNT
$590M
| $288K | ﹤0.01% |
45,444
+7,690
| +20% | +$49.6K |
2023 Q1
5 quarters
|
|
4735
CALL
ResMed
RMD
$31.6B
| $287K | ﹤0.01% |
1,500
+300
| +25% | +$60.9K |
2023 Q3
3 quarters
|
|
4736
ProShares Ultra Bloomberg Crude Oil
UCO
$435M
| $287K | ﹤0.01% |
8,567
-175
| -2% | -$5.68K |
2018 Q4
22 quarters
|
|
4737
State Street SPDR S&P China ETF
GXC
$448M
| $286K | ﹤0.01% |
4,184
-197
| -4% | -$13.9K |
2019 Q4
18 quarters
|
|
4738
CALL
Relmada Therapeutics
RLMD
$384M
| $285K | ﹤0.01% |
95,100
+40,000
| +73% | +$145K |
2024 Q1
1 quarter
|
|
4739
Graham Corp
GHM
$1.07B
| $285K | ﹤0.01% |
10,117
-22,156
| -69% | -$637K |
2015 Q4
34 quarters
|
|
4740
GoPro
GPRO
$279M
| $284K | ﹤0.01% |
200,307
-114,656
| -36% | -$191K |
2014 Q3
39 quarters
|
|
4741
Applied Digital
APLD
$7.59B
| $283K | ﹤0.01% |
47,581
+12,476
| +36% | +$48.4K |
2022 Q2
8 quarters
|
|
4742
Invesco Zacks Multi-Asset Income ETF
CVY
$117M
| $283K | ﹤0.01% |
+11,272
| New | +$285K |
2024 Q2
0 quarters
|
|
|
K
4743
CALL
DELISTED
Kellanova
K
| $283K | ﹤0.01% |
+4,900
| New | +$289K |
2024 Q2
0 quarters
|
|
4744
Invesco S&P Global Water Index ETF
CGW
$1.02B
| $282K | ﹤0.01% |
5,101
-3,863
| -43% | -$218K |
2022 Q4
6 quarters
|
|
|
KYNB
4745
Kyntra Bio
KYNB
$25.5M
| $281K | ﹤0.01% |
12,614
+8,670
| +220% | +$268K |
2014 Q4
38 quarters
|
|
4746
ARS Pharmaceuticals
SPRY
$405M
| $281K | ﹤0.01% |
33,000
-17,183
| -34% | -$152K |
2021 Q1
13 quarters
|
|
4747
PUT
Vanguard Consumer Discretionary ETF
VCR
$5.69B
| $281K | ﹤0.01% |
2,200
-3,300
| -60% | -$1.01M |
2023 Q2
4 quarters
|
|
4748
Cricut
CRCT
$1.37B
| $280K | ﹤0.01% |
46,713
-130,399
| -74% | -$782K |
2021 Q4
10 quarters
|
|
4749
Immunome
IMNM
$2.37B
| $279K | ﹤0.01% |
23,045
+22,317
| +3,066% | +$349K |
2023 Q4
2 quarters
|
|
4750
Invesco S&P MidCap Low Volatility ETF
XMLV
$694M
| $279K | ﹤0.01% |
5,042
+1,487
| +42% | +$82.4K |
2018 Q1
25 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.